Tag: manmeet ahluwalia

19-NEU-6528_brain-tumor_650x450
June 25, 2020/Research

Phase II Trial Evaluates Safety of Pembrolizumab plus SurVaxM in Recurrent Glioblastoma

Will cancer vaccine boost immunotherapy’s efficacy?

18-NEU-4915_650x450-glioblastoma

Taking on Glioblastoma Through Translational Research: 4 Promising Bench-to-Bedside Initiatives

Rationale and status reports on mechanistically diverse strategies

18-NEU-4010-glioblastoma-laser-ablation-650×450
September 17, 2018/Cancer

Tumor Ablation with Chemo-Radiotherapy Consolidation Yields Rare Durable Glioblastoma Remission

No evidence of residual tumor or recurrence at 6.5 years of follow-up

16-NEU-1934-Ahluwalia-650×450
June 2, 2018/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-MDSC
January 15, 2018/Cancer

Survival Benefit of Adjunctive Tumor-Treating Fields Therapy Confirmed in Glioblastoma

First new medical intervention in a decade to demonstrate improved survival

Dr.-Ahluwalia_650x450
August 7, 2017/Research

A New Approach for EGFR-Mutant Non-Small-Cell Lung Cancer?

Radiation plus targeted therapy improves survival rates

#ASCO16_650x450
June 5, 2016/News & Insight

Brain Metastases: Evolving Concepts at ASCO 2016

Clinical approaches in the era of targeted therapy

BackPage 1 of 2Next
Advertisement
Ad